| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/27/2012 | US20120245329 High pressure refolding of monoclonal antibody aggregates |
| 09/27/2012 | US20120245093 Neuronal Viability Factor and Use Thereof |
| 09/27/2012 | US20120244615 Isolated a-type fhf n-terminal domain peptides and methods of use |
| 09/27/2012 | US20120244596 Anticalins |
| 09/27/2012 | US20120244577 Multivalent heteromultimer scaffold design and constructs |
| 09/27/2012 | US20120244189 Treatment of infections |
| 09/27/2012 | US20120244174 Treatment of tauopathies |
| 09/27/2012 | US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 09/27/2012 | US20120244154 Activatable Binding Polypeptides and Methods of Identification and Use Thereof |
| 09/27/2012 | US20120244148 Anti-interferon-alpha antibodies |
| 09/27/2012 | US20120244114 Antigen associated with rheumatoid arthritis |
| 09/27/2012 | US20120244080 Protein agent for diabetes treatment and beta cell imaging |
| 09/27/2012 | CA2830805A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes |
| 09/27/2012 | CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
| 09/27/2012 | CA2830600A1 Compositions and methods for enhancing the pluripotency of stem cells |
| 09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |
| 09/26/2012 | EP2502939A1 Nonnatural collagen-like protein and use thereof |
| 09/26/2012 | EP2501810A1 Methods for producing antibody-producing cells that produce desired polypeptides |
| 09/26/2012 | EP2501719A2 Peptides and methods for the detection of lyme disease antibodies |
| 09/26/2012 | EP2501718A2 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 09/26/2012 | EP2501411A1 Methods for improving oral delivery |
| 09/26/2012 | EP2501407A1 Anti-orai1 antigen binding proteins and uses thereof |
| 09/26/2012 | CN102690354A Recombined dimerization antithrombin III-Fc fusion protein and mammalian cell efficient expression system thereof |
| 09/26/2012 | CN102690353A Method for rapid screening of modified tumor necrosis factor receptor II-adiponectin globular-site fusion protein and application thereof |
| 09/26/2012 | CN102690352A Fusion protein containing GLP-1, and pharmaceutical compositions and applications thereof |
| 09/26/2012 | CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof |
| 09/26/2012 | CN102020717B Active factor for enhancing lymphocyte targeting killing tumors and preparation method thereof |
| 09/26/2012 | CN101974089B Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection |
| 09/26/2012 | CN101875700B Method for improving bioactivity of exendin fusion protein |
| 09/26/2012 | CN101747437B Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein |
| 09/26/2012 | CN101533018B Detection kit for distinguishing cow pathogenic mycobacteria infection from non-pathogenic mycobacteria infection and method thereof |
| 09/26/2012 | CN101253264B 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
| 09/25/2012 | US8273358 Activatable clostridial toxins |
| 09/25/2012 | US8273356 Anti-IgE vaccines |
| 09/25/2012 | US8273353 Inhibitors of vascular endothelial growth factor activity |
| 09/25/2012 | US8273350 Antibodies to human IL-1β |
| 09/25/2012 | CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 09/25/2012 | CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine |
| 09/25/2012 | CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 09/25/2012 | CA2242903C Amino acid-enriched plant protein reserves, particularly lysine-enriched maize .gamma.-zein, and plants expressing such proteins |
| 09/25/2012 | CA2188061C Immunosuppressant target proteins |
| 09/20/2012 | WO2012125652A2 Antibody and antibody mimetic for visualization and ablation of endogenous proteins |
| 09/20/2012 | WO2012125626A2 Decorin compositions and use thereof |
| 09/20/2012 | WO2012125445A2 Small molecule-dependent inteins and uses thereof |
| 09/20/2012 | WO2012125182A1 Npp1 fusion proteins |
| 09/20/2012 | WO2012124998A2 Bio-pin |
| 09/20/2012 | US20120240246 Variant Calpastatins and Variant Calpains for Modulating the Activity or Stability of Calpain |
| 09/20/2012 | US20120238728 Multivalent antibodies and uses therefor |
| 09/20/2012 | US20120238727 Decorin compositions and use thereof |
| 09/20/2012 | US20120238724 Mutated immunoglobulin-binding protein |
| 09/20/2012 | US20120238509 Urocortin 2 analogs and uses thereof |
| 09/20/2012 | US20120238497 Glp-1 fusion peptides, their production and use |
| 09/20/2012 | US20120238496 Fusion protein regulating plasma glucose and lipid, its preparation method and use |
| 09/20/2012 | US20120238039 Novel immobilizing fusion protein for effective and oriented immobilization of antibody on surfaces |
| 09/20/2012 | US20120237978 GPCR Fusion Protein Containing an N-Terminal Autonomously Folding Stable Domain, and Crystals of the Same |
| 09/20/2012 | US20120237977 Activatable Binding Polypeptides and Methods of Identification and Use Thereof |
| 09/20/2012 | US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases |
| 09/20/2012 | US20120237513 Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells |
| 09/20/2012 | US20120237512 Activatable Binding Polypeptides and Methods of Identification and Use Thereof |
| 09/20/2012 | US20120237442 Design and Construction of Novel Multivalent Antibodies |
| 09/20/2012 | CA2852056A1 Anti-cd40 antibodies and uses thereof |
| 09/20/2012 | CA2829767A1 Npp1 fusion proteins |
| 09/19/2012 | EP2500438A2 Novel compositions and methods for the treatment of psoriasis |
| 09/19/2012 | EP2499165A2 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto |
| 09/19/2012 | EP2498808A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 09/19/2012 | CN102676563A Method for preparing human serum albumin-human parathyroid hormone |
| 09/19/2012 | CN102676562A Preparation method and application of fusion protein with broad spectrum adsorption capacity to antibodies |
| 09/19/2012 | CN102676547A Fusion protein containing neutralizing epitope gene of C-terminal of encephalitis-B E protein and vaccine containing fusion protein |
| 09/19/2012 | CN102675473A Gene recombinant human active basic fibroblast growth factor fusion protein, preparation method thereof and application thereof |
| 09/19/2012 | CN102675472A Kit for detecting pig suffering from porcine reproductive and respiratory syndrome |
| 09/19/2012 | CN102675471A Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof |
| 09/19/2012 | CN102675470A SCF (Stem Cell Factor)-Fc fusion protein |
| 09/19/2012 | CN102675469A Novel duck reovirus recombinant sigma B protein antigen, preparation method and application |
| 09/19/2012 | CN102675468A Earthworm extract, as well extraction method and application thereof |
| 09/19/2012 | CN102675467A Fusion protein of human somatostatin 28 peptide and human serum albumin, encoding gene of fusion protein and preparation method for fusion protein |
| 09/19/2012 | CN102675466A Epitope delivery system with Escherichia coli heat labile enterotoxin B subunits serving as carriers |
| 09/19/2012 | CN102675465A Purification method for recombined human II-type tumor necrosis factor receptor and antibody fusion protein |
| 09/19/2012 | CN102675410A Method for preparing branch polypeptide |
| 09/19/2012 | CN102060928B Bombesin-oriented anti-tumor polypeptide and preparation method and application thereof |
| 09/19/2012 | CN101624568B Nanometer molecular biosensor, preparation method and application thereof |
| 09/18/2012 | US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs |
| 09/18/2012 | US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity |
| 09/18/2012 | US8268313 Methods for using inhibitors of vascular endothelial growth factor activity |
| 09/18/2012 | CA2462610C Specific binding agents of human angiopoietin-2 |
| 09/18/2012 | CA2445746C Chimeric immunoreceptor useful in treating human cancers |
| 09/18/2012 | CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/13/2012 | WO2012122125A2 Compositions and methods targeting force generation in kinesin |
| 09/13/2012 | WO2012121577A2 Composition for strengthening tissue regenerative power of stem cell having pten |
| 09/13/2012 | WO2012121395A1 Cholesterol-dependent cytolysin variant and use thereof in dds |
| 09/13/2012 | WO2012121392A1 Azophosphorus compound and azole compound library and method for producing same |
| 09/13/2012 | US20120233726 Novel bacillus thuringiensis gene with lepidopteran activity |
| 09/13/2012 | US20120232249 Method of modulating integrin mediated cellular activity and agents useful for same |
| 09/13/2012 | US20120232010 Compositions and Methods for Treating Bladder Cancer |
| 09/13/2012 | US20120231474 Constructs that allow for detection and quantitation of membrane proteins |
| 09/13/2012 | US20120231030 Multi-epitopic vaccine |
| 09/13/2012 | US20120230995 Polyspecific binding molecules and uses thereof |
| 09/13/2012 | US20120230994 Bladder cancer specific ligand peptides |
| 09/13/2012 | US20120230993 Axl tyrosine kinase inhibitors and methods of making and using the same |
| 09/13/2012 | US20120230992 Vegf-related protein |
| 09/13/2012 | US20120230979 NOGO Receptor Binding Protein |